Technical Analysis for NVTA - Invitae Corporation
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
NR7 | Range Contraction | -3.91% | |
Wide Bands | Range Expansion | -3.91% | |
Wide Bands | Range Expansion | -6.46% | |
Upper Bollinger Band Touch | Strength | -6.46% | |
Gapped Down | Weakness | -6.46% | |
Wide Bands | Range Expansion | -9.89% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
50 DMA Support | about 18 hours ago |
Outside Day | about 18 hours ago |
Down 5% | about 18 hours ago |
Fell Below 50 DMA | about 18 hours ago |
Fell Below Previous Day's Low | about 18 hours ago |
Get a Trading Sidekick!
- Earnings date: 02/22/2023
Invitae Corporation Description
Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Biology Telehealth Telemedicine Genetics Medical Genetics Medical Test Lab Testing Neurological Disorders Molecular Diagnostics Informatics Neurology Software Tools Urological Disorders Genetic Disorder Cardiovascular Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.03 |
52 Week Low | 1.67 |
Average Volume | 7,062,244 |
200-Day Moving Average | 3.07 |
50-Day Moving Average | 2.40 |
20-Day Moving Average | 2.26 |
10-Day Moving Average | 2.54 |
Average True Range | 0.24 |
RSI | 53.92 |
ADX | 29.5 |
+DI | 33.70 |
-DI | 15.02 |
Chandelier Exit (Long, 3 ATRs) | 2.23 |
Chandelier Exit (Short, 3 ATRs) | 2.38 |
Upper Bollinger Bands | 2.90 |
Lower Bollinger Band | 1.61 |
Percent B (%b) | 0.66 |
BandWidth | 57.10 |
MACD Line | 0.10 |
MACD Signal Line | 0.06 |
MACD Histogram | 0.046 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.96 | ||||
Resistance 3 (R3) | 3.00 | 2.87 | 2.88 | ||
Resistance 2 (R2) | 2.87 | 2.74 | 2.85 | 2.85 | |
Resistance 1 (R1) | 2.67 | 2.66 | 2.60 | 2.63 | 2.82 |
Pivot Point | 2.54 | 2.54 | 2.50 | 2.52 | 2.54 |
Support 1 (S1) | 2.33 | 2.41 | 2.27 | 2.29 | 2.10 |
Support 2 (S2) | 2.20 | 2.33 | 2.18 | 2.07 | |
Support 3 (S3) | 2.00 | 2.20 | 2.04 | ||
Support 4 (S4) | 1.96 |